Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Cancer Res. 2011 Feb 15;71(4):1214-8. doi: 10.1158/0008-5472.CAN-10-3277. Epub 2011 Jan 6.
The effect of local therapy, such as surgical lymph node (LN) dissection and radiotherapy, on the survival of cancer patients has been debated for decades. Several lines of recent clinical evidence support that LN metastasis plays significant roles in systemic dissemination of cancer cells, although the effects of surgical LN dissection on survival was downplayed historically because of controversial data. Molecular studies of LN metastasis suggest that the microenvironment within LNs, including chemokines and lymphangiogenesis, can mediate the metastatic spread to the sentinel LNs, and beyond. It has been shown that chemokine receptor CXCR3 is involved in LN metastasis, and its inhibition may improve patient prognosis. Although it remains to be determined whether local therapy is best pursued through LN dissection or through a combination of resection with radiation, prevention of regional metastases is an important goal in the treatment of cancer patients to achieve a better survival.
局部治疗(如手术淋巴结清扫和放疗)对癌症患者生存的影响已经争论了几十年。最近的一些临床证据表明,淋巴结转移在癌细胞的全身扩散中起着重要作用,尽管由于数据存在争议,手术淋巴结清扫对生存的影响在历史上被淡化了。淋巴结转移的分子研究表明,淋巴结内的微环境,包括趋化因子和淋巴管生成,可介导肿瘤细胞向前哨淋巴结及其他部位的转移。已经表明趋化因子受体 CXCR3 参与了淋巴结转移,其抑制可能改善患者的预后。尽管仍需要确定局部治疗是通过淋巴结清扫还是通过手术切除联合放疗来进行,但预防区域转移是癌症患者治疗的一个重要目标,以实现更好的生存。